Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,605 | 816 | 99.1% |
| Gift | $59.40 | 1 | 0.5% |
| Education | $25.00 | 1 | 0.2% |
| Consulting Fee | $25.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,004 | 118 | $0 (2024) |
| Amgen Inc. | $1,530 | 120 | $0 (2024) |
| UCB, Inc. | $1,354 | 86 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,021 | 54 | $0 (2024) |
| GlaxoSmithKline, LLC. | $714.53 | 44 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $658.97 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $555.97 | 32 | $0 (2024) |
| Lilly USA, LLC | $480.78 | 34 | $0 (2024) |
| Janssen Biotech, Inc. | $401.47 | 24 | $0 (2024) |
| Mannkind Corporation | $364.48 | 33 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,385 | 132 | ABBVIE INC. ($418.09) |
| 2023 | $3,089 | 186 | AbbVie Inc. ($694.91) |
| 2022 | $2,550 | 162 | Amgen Inc. ($388.03) |
| 2021 | $2,311 | 169 | Amgen Inc. ($382.01) |
| 2020 | $1,347 | 100 | AbbVie Inc. ($184.39) |
| 2019 | $639.64 | 42 | AbbVie, Inc. ($140.33) |
| 2018 | $77.48 | 6 | Lilly USA, LLC ($26.33) |
| 2017 | $315.16 | 22 | Novo Nordisk Inc ($83.41) |
All Payment Transactions
819 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Obesity | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 660 | 879 | $167,319 | $59,949 |
| 2022 | 25 | 1,407 | 1,684 | $242,582 | $84,817 |
| 2021 | 20 | 1,187 | 1,540 | $185,069 | $57,270 |
| 2020 | 27 | 1,499 | 1,883 | $189,188 | $46,416 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $30,625 | $15,266 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 195 | $57,720 | $14,978 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 145 | $31,610 | $8,243 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 33 | $12,606 | $3,695 | 29.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,360 | $3,088 | 91.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 39 | 39 | $3,666 | $2,805 | 76.5% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 53 | $4,240 | $2,719 | 64.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 42 | $3,360 | $1,934 | 57.5% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 18 | $2,610 | $1,795 | 68.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 45 | $1,415 | $1,313 | 92.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 34 | $2,040 | $1,184 | 58.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 22 | $2,200 | $746.32 | 33.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 14 | 14 | $5,600 | $496.44 | 8.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 14 | $2,086 | $422.35 | 20.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 33 | $1,980 | $339.85 | 17.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $335.00 | $320.87 | 95.8% |
| 90471 | Administration of vaccine | Office | 2023 | 17 | 18 | $576.00 | $271.08 | 47.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 12 | $540.00 | $247.56 | 45.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 15 | $750.00 | $86.47 | 11.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 194 | 194 | $47,530 | $24,405 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 224 | $66,304 | $17,692 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 182 | 284 | $61,912 | $15,315 | 24.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 25 | 25 | $7,500 | $6,930 | 92.4% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 79 | 80 | $6,000 | $5,470 | 91.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 19 | $7,258 | $2,440 | 33.6% |
About Dr. Dana Collins, D.O
Dr. Dana Collins, D.O is a Family Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447312442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dana Collins, D.O has received a total of $12,715 in payments from pharmaceutical and medical device companies, with $2,385 received in 2024. These payments were reported across 819 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($12,605).
As a Medicare-enrolled provider, Collins has provided services to 4,753 Medicare beneficiaries, totaling 5,986 services with total Medicare billing of $248,452. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Greensboro, NC
- Active Since 12/15/2006
- Last Updated 11/20/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447312442
Products in Payments
- Cimzia (Drug) $1,304
- RINVOQ (Biological) $989.69
- Enbrel (Biological) $699.35
- ACTHAR (Biological) $693.70
- COSENTYX (Drug) $540.72
- EVENITY (Biological) $415.15
- AFREZZA (Drug) $364.48
- BENLYSTA (Biological) $333.37
- SKYRIZI (Biological) $317.89
- OFEV (Drug) $305.83
- COSENTYX (Biological) $300.78
- REMICADE (Biological) $279.62
- Kerendia (Drug) $240.09
- NURTEC ODT (Drug) $214.00
- NEXLETOL (Drug) $208.91
- GEMTESA (Drug) $205.98
- MOUNJARO (Drug) $197.61
- FARXIGA (Drug) $195.65
- Otezla (Drug) $193.80
- INJECTAFER (Drug) $188.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greensboro
Mrs. Veita Bland, M.d, M.D
Family Medicine — Payments: $53,051
Alexander Murray, M.d, M.D
Family Medicine — Payments: $48,455
Dr. Robert Cowles, M.d, M.D
Family Medicine — Payments: $31,631
Dr. John Lalonde, M.d, M.D
Family Medicine — Payments: $16,294
Dr. Brent Greenberg, M.d, M.D
Family Medicine — Payments: $10,958
Karen Richter, Md, MD
Family Medicine — Payments: $10,875